페이지 위치 알려주기

김소헌 의사 사진

내분비내과

김소헌

나의 의료진 선택완료

진료일정 진료과 센터

Type1
오전 진료과 진료과 진료과
오후 진료과

"오후진료 13:30 부터 시작"

전문분야

당뇨병, 갑상선질환, 뇌하수체 질환, 비만, 기타 내분비질환

학력

  • 2000.02

    연세대학교 의과대학 졸업
  • 2004.02

    연세대학교 대학원 의학 석사
  • 2008.02

    연세대학교 대학원 의학 박사

주요경력

  • 2023.03 ~ 현재

    인하대병원 내분비내과 과장
  • 2020.03 ~ 현재

    인하대병원 내분비내과 교수
  • 2021.01 ~ 2021.12

    인하대병원 교육수련실 부실장
  • 2015.03 ~ 2020.02

    인하대병원 내분비내과 부교수
  • 2013.01 ~ 2014.01

    Harvard Medical School, Brigham and Women's Hospital
  • 2011.01 ~ 2015.02

    인하대병원 조교수
  • 2009.01 ~ 2011.01

    인하대병원 전임강사
  • 2007.01 ~ 2009.01

    인하대병원 임상강사
  • 2005.01 ~ 2007.01

    신촌세브란스병원 내분비내과 연구강사
  • 2001.01 ~ 2005.01

    신촌세브란스병원 내과 전공의
  • 2000.01 ~ 2001.01

    신촌세브란스병원 수련의

학회활동

  • -

    대한당뇨병학회 국제협력이사(2024-2025)
  • -

    대한비만학회 정보이사(2019-2020)
  • -

    대한당뇨병학회, 대한비만학회, 대한내분비학회 평의원

수상경력

  • 2019.01

    DMJ 최다 피인용 논문상
  • 2018.01

    대한당뇨병학회 우수연제상
  • 2016.01

    대한당뇨병학회 우수포스터상
  • 2011.01

    대한당뇨병학회 우수연제상
  • 2010.01

    대한당뇨병학회 한독 연구비상
  • 2008.01

    한국지질동맥경화학회 Basic Research Award

주요 논문 및 저서

  • 2024

    Seo DH, Kim M, Suh YJ, Cho Y, Ahn SH, Hong S, Kim SH. Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: A nationwide population-based study. Diabetes Res Clin Pract 2024;208:111098. (corresponding)
  • 2023

    Cho Y, Park HS, Huh BW, Lee YH, Seo SH, Seo DH, Ahn SH, Hong S, Kim SH. Non-alcoholic fatty liver disease with sarcopenia and carotid plaque progression risk in patients with type 2 diabetes mellitus. Diabetes Metab J 2023;47:232-41. (corresponding)
  • 2022

    Cho Y, Park HS, Huh BW, Seo SH, Seo DH, Ahn SH, Hong S, Suh YJ, Kim SH. Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus. Diabetes Metab 2022;48(6):101389. (corresponding)
  • 2022

    Seo DH, Suh YJ, Cho Y, Ahn SH, Seo S, Hong S, Lee YH, Choi YJ, Lee E, Kim SH. Effect of low skeletal muscle mass and sarcopenic obesity on chronic kidney disease in patients with type 2 diabetes. Obesity 2022;30:2034-43 (corresponding)
  • 2022

    Seo DH, Suh YJ, Cho Y, Ahn SH, Seo S, Hong S, Lee YH, Choi YJ, Lee E, Kim SH. Advanced liver fibrosis is associated with chronic kidney disease in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. Diabetes Metab J 2022;46:630-9. (corresponding)
  • 2022

    Seo SH, Cho Y, Heo YS, Seo DH, Ahn SH, Hong SB, Suh YJ, Kim SH. Prediction of antidiabetic effect after gastrectomy with Roux-en-Y reconstruction in patients with gastric cancer and type 2 diabetes. Medicine 2022;101(36):e30309. (Corresponding)
  • 2022

    Cho Y, Seo SH, Seo DH, Ahn SH, Hong S, Huh BW, Lee YH, Park SW, Suh YJ, Kim SH. Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function. Sci Rep. 2022;12:9384. (corresponding)
  • 2022

    Seo DH, Cho Y, Seo S, Ahn SH, Hong S, Ha KH, Shim JS, Kim HC, Kim DJ, Kim SH. Association between metabolically healthy obesity and subclinical atherosclerosis in the Cardiovascular and Metabolic Disease Etiology Research Center (CMERC) Cohort. J Clin Med 2022;11(9):2440. (corresponding)
  • 2022

    Seo DH, Suh YJ, Cho Y, Ahn SH, Seo S, Hong S, Lee YH, Choi YJ, Lee E, Kim SH. Effect of dapagliflozin in combination with lobeglitazone and metformin in Korean patients with type 2 diabetes in real-world clinical practice. Yonsei Med J 2022;63:825-33.
  • 2021

    Cho Y, Jeong Y, Seo DH, Ahn SH, Hong S, Suh YJ, Kim SH. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study. Atherosclerosis 2021;328:92-99. (Corresponding)
  • 2021

    Seo DH, Ha KH, Kim SH, Kim DJ. Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea. Endocrinol Metab 2021;36:70-80 (Co-corresponding)
  • 2020

    Seo DH, Nam M, Jung M, Suh YJ, Ahn SH, Hong S, Kim SH. Serum levels of adipocyte fatty acid-binding protein are associated with rapid renal function decline in patients with type 2 diabetes and preserved renal function. Diabetes Metab J 2020;44:875-886. (Corresponding)
  • 2020

    Seo DH, Lee YH, Suh YJ, Ahn SH, Hong S, Choi YJ, Huh BW, Park SW, Lee E, Kim SH. Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2020;305:19-25. (Corresponding)
  • 2020

    Seo DH, Lee YH, Park SW, Choi YJ, Huh BW, Lee E, Huh KB, Kim SH, Cha BS. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. Diabetes Metab 2020;46:362-369. (Corresponding)
  • 2019

    Seo DH, Kim SH, Song JH, Hong S, Suh YJ, Ahn SH, Woo JT, Baik SH, Park Y, Lee KW, Kim YS, Nam M. Presence of carotid plaque is associated with rapid renal function decline in patients with type 2 diabetes mellitus and normal renal function. Diabetes Metab J In press (Co-primary)
  • 2019

    Ahn SH, Seo DH, Cho Y, Jung M, Kim SH, Hong S. Different relationships between thyrotropin and muscle strength according to sex and age in euthyroid Koreans (The 6th Korea National Health and Nutritional Examination Survey 2014-2015). Thyroid 2020, In press
  • 2019

    Lee K, Park IB, Yu SH, Kim SK, Kim SH, Seo DH, Hong S, Jeon JY, Kim DJ, Kim SW, Choi CS, Lee DH. Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis. Diabetes Metab Syndr Obes 2019;12:1161-71.
  • 2018

    Yoo SZ, No MH, Heo JW, Park DH, Kang JH, Kim SH, Kwak HB. Role of exercise in age-related sarcopenia. J Exerc Rehabil 2018:14:551-558.
  • 2018

    Lee EH, Lee YW, Lee KW, Nam M, Kim SH, Song JH A new comprehensive diabetes health literacy scale: Development and psychometric evaluation. Int J Nurs Stud 2018:88:1-8.
  • 2018

    Kim SH, Lee SY, Kim CW, Suh YJ, Hong S, Ahn SH, Seo DH, Nam M, Chon S, Woo J, Baik SH, Park Y, Lee KW, Kim YS. Impact of socioeconomic status on health behaviors, metabolic control and chronic complications in type 2 diabetes mellitus. Diabetes Metab J 2018;42:3890-393.
  • 2018

    Ahn SH, Seo DH, Kim SH, Nam MS, Hong S. The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011. Osteoporos Int 2018;29:181-190.
  • 2017

    Piao SJ, Kim SH, Suh YJ, Hong SB, Ahn SH, Seo DH, Park IS, Nam M. Beneficial effects of aerobic exercise training combined with rosiglitazone on glucose metabolism in Otsuka Long Evans Tokushima Fatty Rats. Diabetes Metab J. 2017;41:674-85. (Co-primary)
  • 2017

    Cho H, Um J, Lee J, Kim W, Kang W, Kim SH, Ha H, Kim Y, Ahn Y, Jung D, Williams D. ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviated the symptoms of type 2 diabetes. Sci Rep 2017;7:44186.
  • 2016

    Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, Kim CW, Lee SY, Lee DH, Hong S, Kim YS, Nam MS. Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes. J Korean Med Sci. 2016;31:924-31. (Co-primary)
  • 2016

    Kim SH, Plutzky J. Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders. Diabetes Metab J. 2016;40:12-21.
  • 2016

    Hong SB, Lee JJ, Kim SH, Suh YJ, Han JY, Kim YS, Nam M. The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016;111:58-65.
  • 2015

    Kim EC, Kim SH, Piao SJ, Kim TJ, Bae K, Kim HS, Hong SS, Lee BI, Nam M. Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo. J Korean Med Sci. 2015;30:979-87.
  • 2014

    Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, Cho SG, Choi YJ, Lee DH, Lee SY, Hong SB, Kim YS, Jeon JY, Nam M. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clin Endocrinol 2014;80(6):825-33.
  • 2013

    Suh YJ, Kim S, Kim SH, Park J, Lim HA, Park HJ, Choi H, Ng D, Lee MK, Nam M. Combined genome-wide linkage and association analyses of fasting glucose level in healthy twins and families of Korea. J Korean Med Sci. 2013;28(3):415-23.
  • 2013

    Hong JT, Lee JH, Kim SH, Hong SB, Nam M, Kim YS, Chu YC. Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma. Korean J Intern Med. 2013;28:236-41. (corresponding)
  • 2012

    Kim SH, Hong SB, Suh YJ, Choi YJ, Nam M, Lee HW, Park IeB, Chon S, Woo JT, Baik SH, Park Y, Kim DJ, Lee KW, Kim YS, KNDP group. Association between nutrient intake and obesity in type 2 diabetic patients from the Korean National Diabetes Program: a cross-sectional study. J Korean Med Sci. 2012;27(10):1188-95.
  • 2011

    Lee DH, Lee SH, An K, Moon JY, Kim SH, Choi YJ, Nam M, Jeon JY. Effects of 6 weeks of lifestyle modification including combined exercise program on the risk of metabolic parameters and macrovascular complications in type 2 diabetic patients. Korean J Obes 2011;20(3)147-159. Korean.
  • 2011

    Choi EJ, Nam M, Kim SH, Park CG, Toobert DJ, Yoo JS, Chu SH. Psychometric properties of a Korean version of the summary of diabetes self-care activities measures. Int J Nurs Stud 2011;48(3):333-7.
  • 2010

    Jin QS, Kim SH, Piao SJ, Lim HA, Lee SY, Hong SB, Kim YS, Lee HJ, Nam M. R1467H variants of Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) are associated with type 2 diabetes mellitus in Koreans. Korean Diabetes J. 2010;34(6):368-73.
  • 2010

    Kim SH, Kim SH, Choi M, Lee Y, Kim YO, Ahn DS, Kim YH, Kang ES, Lee EJ, Jung M, Cho JW, Williams DR, Lee HC. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction. Cardiovasc Res. 2010;87(4):713-22.
  • 2010

    Hong S, Choi Y, Lee HJ, Kim SH, Oe Y, Lee SY, Nam M, Kim YS. Development and validation of a semi-quantitative food frequency questionnaire to assess diets of Korean type 2 diabetic patients. Korean Diabetes J 2010;34(1):32-9.
  • 2009

    Han SJ, Kang ES, Kim HJ, Kim SH, Chun SW, Ahn CW, Cha BS, Nam M, Lee HC. The C609T variant of NQO1 is associated with carotid artery plaques in patients with type 2 diabetes. Mol Genet Metab. 2009;97(1):85-90.
  • 2008

    Kim SH, Kang ES, Hur KY, Lee HJ, Han SJ, Kwak JY, Nam CM, Ahn CW, Cha BS, Lee HC. Adiponectin gene polymorphism 45T>G is associated with carotid artery plaques in patients with type 2 diabetes mellitus. Metabolism. 2008;57(2):274-9.
  • 2008

    Kim SH, Shim WS, Kim EA, Kim EJ, Lee SH, Hong SB, Kim YS, Park SG, Leem JH, Lee HJ, Nam M. The effect of lowering the threshold for diagnosis of impaired fasting glucose. Yonsei Med J. 2008;49(2):217-23.
  • 2008

    Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, Ahn CW, Cha BS, Nam M, Nam CM, Lee HC. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet. 2008;53:991-8.
  • 2008

    Kang ES, Park SE, Han SJ, Kim SH, Nam CM, Ahn CW, Cha BS, Kim KS, Lee HC. LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. Mol Genet Metab. 2008;95:96-100.
  • 2008

    Han SJ, Kang ES, Hur KY, Kim HJ, Kim SH, Yun CO, Choi SE, Ahn CW, Cha BS, Kang Y, Lee HC. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis. Horm Res. 2008;70(3):165-73.
  • 2008

    Hwang JA, Park TC, Jung SH, Kim HJ, Kim DJ, Kim SH, Nam M, Kim TH, Lee MK, Lee KW. Direct medical costs of type 2 diabetic patients in the tertiary hospital. Korean Diabetes J. 2008;32(3):259-268.
  • 2008

    Jekal Y, Lee MK, Kim ES, Park JH, Lee HJ, Han SJ, Kang ES, Lee HC, Kim SH, Jeon JY. Effects of walking and physical activity on glucose regulation among type 2 diabetics. Korean Diabetes J. 2008;32(1):60-67.
  • 2007

    Kim ES, Im JA, Kim KC, Park JH, Suh SH, Kang ES, Kim SH, Jekal Y, Lee CW, Yoon YJ, Lee HC, Jeon JY. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity. 2007;15(12):3023-30.
  • 2007

    Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, Nam CM, Ahn CW, Cha BS, Kim SI, Lee HC. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care. 2007;30(3):609-15.
  • 2007

    Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Clin Endocrinol. 2007;66:282-9.
  • 2006

    Kim SH, Lee SJ, Kang ES, Kang S, Hur KY, Lee HJ, Ahn CW, Cha BS, Yoo JS, Lee HC. Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism. 2006;55(8):1053-9.
  • 2006

    Kang ES, Cha BS, Kim HJ, Kim HJ, Kim SH, Hur KY, Lee HJ, Shim WS, Ahn CW, Lee HC. The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes. Diabetes Care. 2006;29(6):1320-4.
  • 2005

    Kang ES, Park SY, Kim SH, Lee HJ, Hur KY, Han SJ, Park SE, Kim HJ, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. Adiponectin gene polymorphism and carotid artery intima-media thickness in type 2 diabetes. J Korean Soc Endocrinol 2005;20(1)29-39.
  • 2005

    Choi JM, Kim MJ, Lee SW, Song KE, Chung YS, Lee KW, Kim DJ, Choi SH, Kim SH, Cho MH, Rhee Y, Ahn CW, Lim SK, Kim KR. The effect of treatment modalities on survival rates of patients with anaplastic thyroid carcinoma. J Korean Soc Endocrinol. 2005;20(2):127-133.
  • 2004

    Kim SH, Kang ES, Park SY, Lee SJ, Kim MJ, Yoo JS, Ahn CW, Cha BS, Lim SK, Lee HC. The effects of lifestyle modification on the metabolic parameters of type 2 diabetes. J Korean Diabetes Assoc 2004:28(5):441-451.

기타

원하시는 예약유형을 선택해주세요

예약하시고자 하는 의료진의 진료부서를 선택해주세요